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Abstract
Background: In several neuropathological conditions, microglia can become overactivated and cause neurotoxicity
by initiating neuronal damage in response to pro-inflammatory stimuli. Our previous studies have shown that
exposure to electromagnetic fields (EMF) activates cultured microglia to produce tumor necrosis factor (TNF)-a and
nitric oxide (NO) through signal transduction involving the activator of transcription STAT3. Here, we investigated
the role of STAT3 signaling in EMF-induced microglial activation and pro-inﬂammatory responses in more detail
than the previous study.
Methods: N9 microglial cells were treated with EMF exposure or a sham treatment, with or without pretreatment
with an inhibitor (Pyridone 6, P6) of the Janus family of tyrosine kinases (JAK). The activation state of microglia was
assessed via immunoreaction using the microglial marker CD11b. Levels of inducible nitric oxide synthase (iNOS),
TNF-a and NO were measured using real-time reverse transcription-polymerase chain reaction (RT-PCR), enzyme-
linked immunosorbent assay (ELISA) and the nitrate reductase method. Activation of JAKs and STAT3 proteins was
evaluated by western blotting for specific tyrosine phosphorylation. The ability of STAT3 to bind to DNA was
detected with an electrophoresis mobility shift assay (EMSA).
Results: EMF was found to significantly induce phosphorylation of JAK2 and STAT3, and DNA-binding ability of
STAT3 in N9 microglia. In addition, EMF dramatically increased the expression of CD11b, TNF-a and iNOS, and the
production of NO. P6 strongly suppressed the phosphorylation of JAK2 and STAT3 and diminished STAT3 activity in
EMF-stimulated microglia. Interestingly, expression of CD11b as well as gene expression and production of TNF-a
and iNOS were suppressed by P6 at 12 h, but not at 3 h, after EMF exposure.
Conclusions: EMF exposure directly triggers initial activation of microglia and produces a significant pro-
inflammatory response. Our findings confirm that the JAK2-STAT3 pathway may not mediate this initial microglial
activation but does promote pro-inflammatory responses in EMF-stimulated microglial cells. Thus, the JAK2-STAT3
pathway might be a therapeutic target for reducing pro-inflammatory responses in EMF-activated microglia.
Background
The rapid development of society and technology has
led to an unprecedented increase in the number and
diversity of sources of electromagnetic fields (EMFs),
including power lines, electric appliances, radio trans-
mitters, and microwave sources. Numerous studies have
investigated the effects of occupational or residential
exposure to EMF, which has been identified as the
fourth largest pollution hazard [1-7]. Several studies
have suggested that biological systems exhibit a specific
sensitivity to 2.45 GHz microwaves (a water resonance
frequency), which is widely used in household appli-
ances, medical applications and communication systems.
While some of these results have been difficult to repro-
duce, or have severe methodological shortcomings [8,9],
other studies have reported that occupational exposure
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heimer’s disease [13-15]. Therefore, the effects of EMF
exposure on the central nervous system (CNS) have
been an active topic of investigation in recent years. Sev-
eral studies have revealed strong glial reactivity in differ-
ent parts of the brain after EMF exposure [16-19]. We
have found activated microglia in the hippocampus and
cortex of rats after exposure to EMF (unpublished
results). In vivo animal experiments involving microglial
activation, however, cannot clearly explain whether such
activation is induced directly by EMF or indirectly as a
consequence of neuronal injury from EMF exposure.
Microglia, the resident innate immune cells in the
CNS, become activated in response to certain cues,
such as brain injury and immunological stimuli [20,21].
Activated microglia undergo a dramatic morphological
transformation. They then become motile and acquire
a reactive profile that is characterized by proliferation,
migration and phagocytosis [22-28]. Overactivated
microglia can result in disastrous and progressive neu-
rotoxic consequences, however, leading to excess pro-
duction of factors such as superoxide [29], nitric oxide
(NO) [30-32] and tumor necrosis factor-a (TNF-a)
[33-36] that cause additional neuroinflammation
[37-40]. Not surprisingly, activated microglia are
important in the pathogenesis of neurodegenerative
diseases, such as Alzheimer’s disease [41], Parkinson’s
disease [42,43] and amyotrophic lateral sclerosis
[44-46].
The signal transduction mechanisms involved in
microglial activation and neuroinflammatory factors
release after EMF exposure are still largely unknown.
Microglia may be the principal target of the neurobiolo-
gical effects of EMF. In response to extracellular stimuli,
several major signaling pathways are upregulated in acti-
vated microglia. Several transcription factors, i.e., NF-B,
AP-1 and C/EBP, are involved in microglial activation in
vivo and in vitro [47-49]. STAT signaling is another cri-
tical pathway that plays an important regulatory role in
microglial reactivity to various stimuli, including cere-
bral ischemia, gangliosides, lipopolysaccharide, thrombin
and cytokines [50-55]. We have previously shown that
the JAK-STAT3 pathway is activated in EMF-stimulated
microglia [56]. It is not known, however, whether JAK-
STAT3 signaling triggers the initial activation of EMF-
stimulated microglia or whether it merely participates in
the pro-inflammatory responses. Recently, a JAK inhibi-
tor I (pyridone 6, P6), capable of producing complete
inhibition of STAT3 activation, was shown to not alter
the growth characteristics of tested cell lines even when
used in a high μM range of concentrations. This obser-
vation suggests that persistent STAT3 inhibition with
P6 may be a helpful tool in addressing the aforemen-
tioned questions.
Imbalanced microglial activation or hyperactivation
can cause neurodegeneration, but the true initial trigger
(s) of microglial activation has not been identified [57].
Furthermore, the role of the JAK-STAT signaling path-
ways in EMF-stimulated microglia has not yet been
investigated. Hence, we exposed cultured N9 microglia
to 2.45 GHz electromagnetic fields and examined micro-
glial activation, the release of pro-inflammatory factors,
and the role of the JAK-STAT signaling pathway in this
process.
Methods
Cell culture
The mouse microglial cell line N9 was a gift from Dr.
Bai Yun (Department of Genetics, The Third Military
Medical University, China) and was cultured as
described in the original publications [58,59]. Brieﬂy,
c e l l sw e r eg r o w ni nI s c o v e ’s modified Dulbecco’sm e d -
ium (IMDM; HyClone, Logan, UT) supplemented with
5% heat-inactivated fetal bovine serum (FBS; HyClone),
2 mM glutamine, 100 U/ml penicillin, 100 μg/ml strep-
tomycin, and 50 μM 2-mercaptoethanol (Sigma-Aldrich,
S t .L o u i s ,M O ) .C e l l sw e r es e e d e di n2 5 - c m
2 T-flasks
(1×10
6 cells/flask) or 6-well plates (5×10
5 cells/well) at
37°C in a humidified 5% CO2 atmosphere. The medium
was exchanged for serum-free IMDM after 24 h. Cells
were then pretreated with or without P6 (10 μM;
Calbiochem, La Jolla, CA) or a solvent control (tissue
culture grade dimethylsulfoxide (DMSO; Sigma-
Aldrich)) for 1 h prior to EMF stimulation.
Exposure system
Pulsed EMF exposure was carried out in an anechoic
chamber, and the ambient air temperature inside the
anechoic chamber was 25-26°C. Pulsed EMF was deliv-
ered through a rectangular horn antenna connected hor-
izontally to a handset (Philips PM 7320X). The radiation
was directed vertically downward toward the exposure
flasks using a reflector. The microwave transmitter was
operated at 2.45 GHz at an average pulsed power of
90 mW. The pulse width was 2 μs, and the pulse repeti-
tion rate was 500 pps. A 20-min exposure to 2.45 GHz
pulsed microwaves at an average specific absorption rate
(SAR) of 6 W/kg was performed. During the 20-min
exposure period, the distance from the face of the
antenna horn to the surface of the flasks where the cells
were settled was 90 cm. For EMF exposure, four flasks
were placed into the upper chamber of a Perspex™ water
bath (24.5 × 21 cm). The temperature of the medium in
the flasks in the upper chamber was maintained at 37°C
by circulating heated water through the lower closed
chamber. During sham exposure, four T-25 flasks were
placed in the same conditions for the same period of
time as the EMF-exposed group, except for the EMF
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was performed to calculate the SAR value [60].
Enzyme-linked immunosorbent assay (ELISA) of TNF-a
TNF-a release in cultured supernatants was determined
using a mouse TNF-a ELISA kit (eBioscience, San
Diego, CA). Briefly, ELISA plates (96-well; NUNC Maxi-
Sorp, eBioscience) were coated with coating buffer
(100 μl/well), sealed and incubated overnight at 4°C.
The wells were washed 5 times with wash buffer and
blocked with assay diluent at room temperature for 1 h.
The samples (100 μl) collected from N9 cultures were
added to each well and incubated overnight at 4°C for
maximal sensitivity. Subsequently each plate was incu-
bated with the detection antibody (100 μl/well) diluted
in assay buffer for 1 h and then avidin-HRP (100 μl/
w e l l )d i l u t e di na s s a yd i l u e n tf o r3 0m i na tr o o mt e m -
perature. Each plate was subsequently incubated with
tetramethylbenzidine (TMB) substrate solution for
15 min; the reaction was stopped with 50 μlo f2N
H2SO4 stop solution. The results were read using a
microplate spectrophotometer at 540 nm. A standard
curve prepared from recombinant TNF-a was used to
calculate the TNF-a production of the samples.
Nitric oxide determination in culture medium
NO was measured as released NO metabolites (nitrates
and nitrites) using an NO detection kit (Nanjing Jian-
cheng Bioengineering Institute, Nanjing, CN). This
method uses nitrate reductase to specifically reduce
NO
3- to NO
2-, and the content of NO
2- is determined
colorimetrically. Briefly, 100 μl of incubation medium
and a standard were added to the wells. Then, 50 μlo f
nicotinamide adenine dinucleotide (NADH) and nitrate
reductase was added. After 30 min, 100 μlo fG r e i s s
reagents I and II was added and incubated for 10 min at
room temperature. The optical density of each well was
determined using a microplate reader set at 540 nm.
Flow cytometry
Expression of microglial marker CD11b [61] was mea-
sured by fluorescence-activated cell sorting (FACS) ana-
lysis to assess activation state of microglial cells. Briefly,
after 20 min of EMF or sham exposure, microglial cells
were washed three times with flow buffer (phosphate-
buffered saline (PBS) containing 0.1% (w/v) sodium
azide and 1% (w/v) BSA) and re-suspended in 250 μlo f
ice-cold flow buffer. Cells were pre-incubated with goat
serum (Zhongshan Goldenbridge Biotechnology (Zsbio),
Beijing, CN) for 20 min at 4°C to block non-specific
binding to Fc receptors. Cells were then spun down at
5,000 rpm, washed three times with flow buffer, and
incubated with rat anti-mouse monoclonal antibody
CD11b (1:100; AbD Serotec, Oxford, UK) or rat IgG2b
isotype control (1:100; AbD Serotec) for 1 h at 4°C.
Centrifugation and washing steps were repeated, and
cells were then incubated with goat anti-rat IgG-
DyLight®549 (1:200; AbD Serotec) for 1 h at 4°C in the
dark. Quantitative analysis was performed using a
FACSCalibur system (BD Biosciences, San Jose, CA).
Confocal microscopy with double-label
immunofluorescence
As previously described [62], cultured cells were fixed
and permeabilized. Cells were then pre-incubated with
goat serum (Zsbio) for 20 min at room temperature and
then washed 3 times with flow buffer. For immunoﬂuor-
escence labeling, cell cultures were incubated with one
of the following antibodies for 1 h at 37°C: rat anti-
mouse monoclonal antibody CD11b (1:100; AbD Sero-
tec) and rabbit anti-mouse monoclonal pTyr705-STAT3
antibodies (p-STAT3, 1:100; Cell Signaling Technology,
Danvers, USA). For confocal microscopy of the double-
labeled samples, cell cultures were incubated simulta-
neously with goat anti-rat IgG-DyLight®549 (1:200; AbD
Serotec) and sheep anti-rabbit IgG-FITC (1:200; Sigma-
Aldrich, St. Louis, USA) for 1 h at 37°C in the dark.
Cell cultures were then washed and mounted with aqu-
eous-based anti-fade mounting medium. Images of
stained cells were captured using a Leica TCS-SP5
confocal laser scanning microscope (Leica, Mannheim,
Germany). Image analysis was performed with a semi-
quantitative method. Fluorescence intensity was
measured using software Image J 1.42.
Western blotting
Cells were washed with ice-cold PBS and scraped in
RIPA lysis buffer (Roche, Penzberg, Germany) contain-
ing protease inhibitors. Whole cell extracts (80 μg/lane)
were separated by 8% SDS PAGE under reducing condi-
tions and then transferred onto nitrocellulose mem-
branes (Millipore, Bedford, USA). The membranes were
blocked with a special Odyssey blocking buffer (LI-COR,
Lincoln, USA) for 3 h at room temperature. The pro-
teins were detected by incubation at ambient tempera-
ture with monoclonal antibodies for p-STAT3 (1:1000;
Cell Signaling Technology), STAT3 (1:1000; Cell Signal-
ing Technology), phospho-JAK1 Tyr-1022/1023
(p-JAK1, 1:2000; Santa-Cruz Biotechnology, Santa Cruz,
CA), JAK 1 (1:1000; Cell Signaling Technology), phos-
pho-JAK2 Tyr-1007/1008 (p-JAK2, 1:2000; Santa-Cruz
Biotechnology), and JAK2 (1:1000; Cell Signaling Tech-
nology) for 3 h. Membranes were washed four times for
5 min each in tris-buffered saline Tween-20 (TBST) and
then incubated with a fluorescently-labeled secondary
antibody (1:5000, LI-COR) for 30 min at room tempera-
ture with gentle shaking. After the final washes with
PBS, the signal was detected and quantified with the
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controls were detected with mouse monoclonal anti-b-
actin antibody (1:5000, Sigma-Aldrich).
Electrophoresis mobility shift assay (EMSA)
The electrophoresis mobility shift assay (EMSA) for
nucleoprotein extracts (10 μg) was performed using the
Odyssey Infrared EMSA Kit (LI-COR) according to the
manufacturer’s instructions. The following double-strand
oligonucleotides were used as specific labeled probes or
cold competitors: 5′-GAT CCT TCT GGG AAT TCC
TAG ATC-3′,3 ′-CTA GGA AGA CCC TTA AGG ATC
TAG-5′. Nuclear extract and STAT3 IRDye™ 700 infra-
red dye-labeled oligonucleotides (LI-COR) were incu-
bated according to the manufacturer’s instructions. The
mixture was incubated for 30 min at 30°C. Electrophor-
esis was performed at 10 V/cm at 4°C using 5% native
polyacrylamide gels. The gels were scanned with the
Odyssey scan bed (LI-COR).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated using Trizol (1 ml/well; Roche,
Penzberg, DE) from 6-well plates according to the
manufacturer’s protocol. The integrity of the RNA
sample was confirmed with gel electrophoresis and by
reverse transcription-PCR using primers for house-
keeping genes. Moloney murine leukemia virus (M-
MLV) reverse transcriptase (Toyobo, Tokyo, Japan)
was used to convert 1 μgo ft o t a lR N Ai n t oc D N Aa t
42°C. The RT-PCR exponential phase was determined
to be 20-32 cycles for semiquantitative comparisons. b-
Actin was measured as a loading control. The amplifi-
cation of cDNA was performed with the following
primers: mouse b-actin [GenBank: 007393.2]: forward
5′-TAAAGACCTCTATGCCAACACAGT-3′; reverse
5′-CACGATGGAGGGGCCGGACTCATC-3′. iNOS
[GenBank: 010927.2]: forward 5′-AACTGTAGCACAG-
CACAGGAAA-3′;r e v e r s e5 ′-ACAAGATCAGGAGG-
GATTTCAA-3′. TNF-a [GenBank: 013693.2]: forward
5′-GCCTATGTCTCAGCCTCTTCTC-3′; reverse 5′-
GGAGGTTGACTTTCTCCTGGTA-3′. The amplifica-
tion reaction was carried out in a Perkin-Elmer Gen-
eAmp (Perkin Elmer, Boston, USA). The resulting PCR
products were separated in 1.5% agarose gels and
visualized with ethidium bromide staining. For semi-
quantitative evaluation, densitometric analysis was per-
formed using Quantity One software (Bio-Rad, Her-
cules, USA).
Statistical analysis
Data are presented as the mean of each treatment group ±
standard deviation of the mean (SD). Statistical differences
between the groups were assessed by one-way analysis of
variance (ANOVA) followed by Duncan’s Multiple Range
test. Statistical significance was established at P < 0.05
unless otherwise indicated.
Results
Effect of EMF exposure on CD11b expression in N9 cells
It has been previously suggested that activated microglia
express different proteins and surface markers. Of these,
CD11b has the greatest biological significance [63,64].
Because increased expression of CD11b is a typical feature
of microglial activation [65], we assessed the effect of EMF
exposure on the expression of CD11b in N9 cells by FACS
and confocal microscopy. EMF was found to significantly
increase CD11b expression (Figure 1 &2I). Figure 1 clearly
shows increases in CD11b expression by N9 cells 3 h and
12 h after EMF exposure (red line). A similar pattern was
observed with immunolocalization and confocal micro-
scopy. Immunofluorescence reaction was significantly
increased 12 h after EMF exposure (Figure 2I). In contrast,
no increase in CD11b expression was observed in the
sham-exposure control groups (Figure 1, 2C &2F).
Effect of EMF exposure on TNF-a, iNOS expression and
NO release from N9 cells
Given the pro-inflammatory effect of EMF exposure on
microglia, we measured levels of TNF-a and iNOS, and
the resulting NO production, in cell culture medium
supernatants at the indicated times after EMF exposure.
A ss h o w ni nF i g u r e3 A ,E M Fe x p o s u r es i g n i f i c a n t l y
induced expression of TNF-a and iNOS. RT-PCR analy-
sis showed that the levels of TNF-a and iNOS mRNA
peaked at 3 h and 6 h, respectively, and were sustained
up to 24 h after EMF exposure (Figure 3B). Because
iNOS is an inducible enzyme, we examined its activity
by measuring the amount of nitrite converted from NO
in the medium using a Griess reagent. Release of NO
was found to peak at 6 h and to remain high up to 24 h
after EMF exposure (Figure 3D). Next, the secretion of
TNF-a was measured by ELISA. Production of TNF-a
reached its first peak at 3 h, gradually decreased, peaked
again at 12 h and was then sustained for up to 24 h
after EMF exposure (Figure 3C).
Effect of EMF exposure on phosphorylation and DNA-
binding activity of STAT3 in N9 cells
In previous work, we have shown that activation of JAKs
and STAT3 is involved in EMF-activated microglia [56].
To further determine the timing of STAT3 activation in
EMF-stimulated microglia, we studied the immunolocali-
zation, phosphorylation and DNA-binding activity of
STAT3 at the indicated times. EMF exposure was found
to result in strongly phosphorylated STAT3 in a time-
dependent manner, with the peak activation occurring at
12 h (Figure 4A). The total amount of STAT3 did not
change in response to EMF emission. Immunolocalization
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STAT3 phosphorylation, showing a strong increase in
fluorescence intensity in N9 cells at 12 h after EMF expo-
sure (Figure 2G). In contrast, a low level of STAT3 phos-
phorylation was observed in the untreated (0 h) group
(Figure 2A &4A).
Under basal conditions, STATs are located in the
cytoplasm; however, when these transcription factors
become phosphorylated, they translocate to the nucleus
within minutes [66]. Accordingly, we performed gel
mobility shift assays to analyze the ability of STAT3 to
bind DNA. Figure 4C shows a specific DNA-protein
complex that is slightly apparent at 1 h after EMF expo-
sure, more fully apparent at 3 h and peaks at 12 h after
EMF exposure. No protein-DNA complex formation
was observed in the control group. The following
experiments with the JAK inhibitor P6 were performed
at the 3 and 12 h points.
Figure 1 Flow cytometry analysis of the effect of EMF exposure on CD11b expression in N9 cells. Microglia were pretreated with (+) or
without (-) P6 (10 μM) for 1 h and then exposed to 2.45 GHz EMF (+) or sham-exposed (-) for 20 min. Untreated cultures were used as a
control. Cells were incubated with rat anti-mouse monoclonal antibody CD11b or isotype control for 1 h at 4°C and then incubated with goat
anti-rat IgG-DyLight®549 for 1 h at 4°C in the dark. In total, 10,000 cells were labeled (CD11b; rat monoclonal, 1:100; rat IgG2b isotype control,
1:100; DyLight®549-conjugated goat anti-rat secondary, 1:200), gated and analyzed by flow cytometry. Histogram overlays show the expression of
CD11b. The dashed lines represent the isotype control. (A) Representative histograms for CD11b expression at 3 h after EMF exposure. (B)
Representative histograms for CD11b expression at 12 h after EMF exposure. (C) Mean fluorescence intensity of CD11b shows averaged values
from three independent experiments as normalized to the control. CD11b expression was found to be significantly increased at 3 h after EMF
exposure; a slight but significant increase was still apparent after P6 pretreatment. CD11b expression was found to be strongly expressed at 12 h
after EMF exposure; this increase was significantly inhibited by P6 at 12 h after EMF exposure. Results are presented as mean ± S.D. of three
independent experiments. Statistical comparisons to control are indicated by * p < 0.05; ** p < 0.01.
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Confocal immunofluorescence microscopy was performed on cultures that were immunoreacted with antibodies against phospho-STAT3 tyr705
(left, rabbit monoclonal, 1:100; FITC-conjugated sheep anti- rabbit secondary, 1:200) and CD11b (right, as Figure 1 shows) at 12 h after EMF
exposure (A-L). (A-C) Untreated cultures were used as a control. (D-F) Cultures pretreated with P6 (10 μM). (G-I) EMF induced more
phosphorylation of STAT3 (green) and expression of CD11b (red) in N9 cells. (J-L) P6 inhibits the phosphorylation of STAT3 and expression of
CD11b at 12 h after EMF exposure. (M-O) P6 pretreatment significantly suppresses the phosphorylation of STAT3, but a slight and significant
increase of CD11b is still apparent at 3 h after EMF exposure. Scale bar 10 μm. (P) Bar graphs show semi-quantification of fluorescence intensity
for p-STAT3 and CD11b in N9 cells. Results are presented as mean ± S.D. of three independent experiments. Statistical comparisons to control
are indicated by * p < 0.05; ** p < 0.01.
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phosphorylation in N9 cells
Given the above results, we focused our studies on the
upstream tyrosine kinases of the STAT3 signaling
molecule, i.e., the JAKs [67], and performed a time
course study of the phosphorylation of JAKs in EMF-
stimulated N9 microglia. Western blots showed dra-
matic phosphorylation of JAK2 but not JAK1 in N9
cells at 1, 3, 6, 12 and 24 h after EMF exposure (Figure
5). Figure 5B shows a low level of JAK1 phosphoryla-
tion that occurred immediately at 1 h after EMF expo-
sure; JAK1 phosphorylation subsequently returned to
basal levels. In contrast, phosphorylation of JAK2 was
found to increase over a period of several hours, show-
ing kinetics similar to those of STAT3 phosphorylation
(Figure 5C). JAK2 phosphorylation was also apparent
at low levels in the control group. The total amount of
J A K 1a n dJ A K 2d i dn o tc h a n g ei nr e s p o n s et oE M F
stimulation.
Inhibitory effect of P6 on EMF-induced CD11b, TNF-a and
iNOS expression and NO release
To further assess the potential role of the JAK2-STAT3
pathway in EMF-induced activation and pro-inflamma-
tory responses of N9 microglia, we examined whether
the JAK inhibitor P6 could affect EMF-induced increase
of TNF-a, iNOS and NO, and the initial activation of
microglia. Western blot analysis and EMSA experiments
show that P6 preconditioning completely blocks activa-
tion of JAK2 and STAT3 at 3 and 12 h after EMF expo-
sure (Figure 4 &5). Our results also show that P6
preconditioning reduces CD11b expression (Figure 1B
&2L), decreases expression of iNOS and TNF-a,a n d
blocks NO release at 12 h after EMF exposure (Figure
3). Interestingly, the fluorescence intensity of CD11b
was found to still be significantly increased at 3 h after
EMF exposure even with P6 preconditioning (Figure 1A,
2O). In addition, P6 preconditioning was found to have
a slight inhibitory effect on TNF-a and iNOS mRNA
Figure 3 EMF exposure induces TNF-a and iNOS expression and NO release from N9 cells. Experiments were performed as described
above. (A) RT-PCR analysis showing that EMF exposure significantly induces the mRNA expression of TNF-a and iNOS. (B) Mean ± S.D. of mRNA
levels from five pooled samples per time point. (C) The concentration of TNF-a in the medium was determined by ELISA after cells were treated
at the indicated time points. (D) The amount of nitrite was determined by the Griess reaction. Results are presented as the mean ± S.D. of five
independent experiments. Statistical comparisons to control are indicated by * p < 0.05; ** p < 0.01; *** p < 0.001. Statistical comparisons
between EMF treatment group and P6 preconditioning are indicated by # p < 0.05; ## p < 0.01; ### p < 0.001.
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sure (Figure 3).
Discussion
In the present study, we observed N9 microglial activation
and pro-inflammatory responses after EMF exposure. We
found that the JAK2-STAT3 pathway is activated in EMF-
stimulated N9 microglial cells. The activation of microglia
and the secretion of pro-inflammatory factors were signifi-
cantly reduced by P6 treatment at 12 h after EMF expo-
sure, while P6 preconditioning did not inhibit the above
processes at 3 h post exposure. Our data suggest that
the JAK2-STAT3 pathway may play a pivotal role in the
pro-inflammatory response but not in the initial activation
of microglia after EMF exposure.
It has been reported that increased CD11b expression
corresponds to extent of microglial activation [63,64,68].
Here, we observed a dramatic increase in CD11b expres-
sion in an in vitro model exposing N9 cells to 2.45 GHz
using a waveguide system that simulates occupational or
residential exposure, at a specific absorption rate (SAR)
of 6 W/kg. This result suggests that EMF may poten-
tially affect microglial activation. Our data are consistent
with earlier findings demonstrating increased glial reac-
tivity in a model using about 900 MHz from a global
system for mobile communication, at a high SAR of 6
Figure 4 EMF exposure induces expression of p-STAT3 and its DNA-binding activity. Experiments were performed as described above. The
protein samples were harvested at the indicated times after EMF exposure in N9 cells. b-Actin antibody was used as a control for equal protein
loading. (A) Western blot analysis showing STAT3 activation with antibodies against phospho-STAT3 tyr705 and STAT3; p-STAT3 was labeled with
green fluorescence and total STAT3 was labeled with red fluorescence. (B) The amount of p-STAT3 or STAT3/actin ratio was determined by
densitometric analysis with software Image J 1.42. (C) STAT3 DNA-binding activity was measured by electrophoretic mobility-shift assays after
EMF exposure. No nuclear extract was added to the labeled STAT3 probe (lane 1). EMF sham exposure was used as a control (lane 2). DNA
binding was noted at 1, 3, 6, 12 and 24 h after EMF exposure (lane 3-7). P6 inhibited EMF-induced binding activity to STAT3 (lane 8-9).
Unlabelled STAT3 was used as competitor DNA at a 200-fold molar excess (Lane 10). A super-shift assay was conducted by pre-incubating of
nuclear extracts with anti-STAT3 (lane 11). Results are presented as mean ± S.D. of three independent experiments. Statistical comparisons to
control are indicated by * p < 0.05; ** p < 0.01; *** p < 0.001.
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argued that EMF exposure does not lead to microglial
activation at low SAR values simulating either micro-
wave radiation or mobile telephone radiofrequency fields
[70-72]. Taken together, these studies show microglial
reactivity only in model systems with high SAR values
of up to 6 W/kg. Thus, we consider that high-energy
EMF, with definite thermal effects [73], could potentially
induce microglial activation.
Microglia are known to be exquisite sensors of even
minor pathological changes in the CNS [28,61]. They
also act as active contributors to neuronal damage in
neurodegenerative diseases such as Alzheimer’s disease,
Parkinson’s disease and HIV dementia [74,75]. An
increasing amount of evidence suggests that migroglia
are key factors in the process of neuroinflammation
[74]. Microglia-induced neuronal injury may be
mediated by the production of TNF-a, NO, and reactive
oxygen species [76-78]. Our results confirm significant
up-regulation of TNF-a and iNOS mRNA, and release
o ft h ep r o - i n f l a m m a t o r yf a c t o r sT N F - a and NO, in N9
microglia after EMF exposure. These results suggest
that EMF, as an external physical factor, could facilitate
microglia pro-inflammatory responses through the
secretion of pro-inflammatory factors. This activity may
ultimately contribute to CNS impairment or disease.
It is well known that microglia monitor the external
environment [61] and respond to external stimuli [79]
via signaling cascades that allow them to perturb mem-
brane function and trigger the activation of one or more
intracellular signaling pathways [75]. In contrast, there
is a lack of information regarding signal transduction
mechanisms and molecular targets of EMF-activated
microglia. Here, our time course experiments show dif-
ferent expression levels of the JAK-STAT pathway in
EMF-activated microglia. It has been demonstrated that
the JAK-STAT cascade plays an essential role in driving
a variety of immune responses in glial cells in the brain
[54,80]. Different expression levels of the JAK-STAT
pathway have been detected in glial cells in the brain
[51-53,76,80-82] and associated with pathological CNS
conditions such as cerebral ischemia[52,55,83], trau-
matic brain injury [84,85] and brain inflammation [86].
These observations suggest that EMF exposure likely
affects microglial activation through the activation of
the JAK-STAT pathway.
Figure 5 EMF exposure induces phosphorylation of JAKs in N9 cells. Experiments were performed as described above. (A) EMF exposure
induces phosphorylation of JAK1 and JAK2 as determined by antibodies against phospho-JAK1 Tyr-1022/1023, JAK1, phospho-JAK2 Tyr-1007/
1008 and JAK2. (B) The p-JAK1 or JAK1/actin ratio was determined by densitometric analysis. (C) The p-JAK2 or JAK2/actin ratio was determined
by densitometric analysis. Results are presented as mean ± S.D. of three independent experiments. Statistical comparisons to control are
indicated by * p < 0.05; ** p < 0.01; *** p < 0.001.
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pathway in EMF-activated microglia, we next examined
whether the JAK inhibitor P6 could affect the EMF-
induced increases of TNF-a,i N O S ,N Oa n dC D 1 1 b .P 6
can effectively block the activation of JAK1, JAK2 and
STAT3 [87,88]. Our results revealed that the activation
of JAK2 increased with kinetics similar to those of phos-
phorylated-STAT3. The activation of JAK2 and STAT3
was significantly inhibited by P6 at 3 and 12 h after
EMF exposure. These results provide further evidence
that JAK2-STAT3 signaling plays a role in the reactivity
of EMF-stimulated microglia.
Most previous studies have shown that the JAK-STAT
signaling pathway is involved in microglial activation
[50-55]. In our study, the activation of microglia, the
transcription of TNF-a and iNOS, and the secretion of
TNF-a and NO were not significantly inhibited at 3 h
by P6 in EMF-activated microglia, however. These
results suggest that the JAK2-STAT3 pathway may not
mediate the initial activation of microglia after EMF
exposure. Other signaling pathways may be involved in
this process. Chang et al.[89] reported that microglial
inactivation by ketamine is at least partially due to the
inhibition of ERK1/2 phosphorylation. Ryu et al. [90]
reported that thrombin induces NO release from
cultured rat microglia via protein kinase C, mitogen-
activated protein kinase,a n dN F - k a p p aB .T h u s ,w e
speculate that EMF exposure activates microglia through
other signaling pathways.
It has been demonstrated that activated microglia
secrete a diverse range of pro-inflammatory and neuro-
toxic factors such as superoxide, TNF-a,i n t e r l e u k i n
(IL)-1b, IL-6 and NO [74]. The cytokines IL-1b and
TNF-a, as mentioned above, may stimulate microglia to
produce monocyte chemoattractant protein (MCP)-1,
macrophage inﬂammatory protein (MIP)-1a,a n dM I P -
1b, which also may contribute to neuroinflammation
[91]. After becoming activated by cytokines, microglia
also release more cytokines into the extracellular space,
thus forming an autocrine loop with positive feedback
between microglial activation and cytokine production.
This loop could explain the maintenance of microglial
activation and the enhancement of pro-inflammatory
responses for 24 h after EMF exposure. Several reports
have reported that STAT3 acts as a transcription factor
in modulating cytokine-induced pro- and anti-inflamma-
tory responses [92,93]. Recently, Tanabe et al. [94]
reported that TNF-a induces IL-6 synthesis through the
JAK/STAT3 pathway in rat C6 glioma cells. Mir et al.
[95] indicated that the enhancing effect of TNF-a on
IFN-g induced iNOS/NO generation is dependent on
the JAK-STAT signaling pathway. In this study, P6 was
found to reduce CD11b expression, decrease the expres-
sion of TNF-a and iNOS, and relieve the release of
TNF-a and NO at 12 h in EMF-activated microglia.
Our data suggest that a feedback loop may be formed to
maintain the activation of microglia and extend the pro-
inflammatory responses through the JAK2-STAT3 path-
way. Based on these data, we hypothesize that after
EMF exposure: (i) there mightb es o m eo t h e rs i g n a l i n g
pathway that rapidly activates microglia; (ii) pro-inflam-
matory factors secreted by activated microglia may
activate the JAK-STAT pathway; and (iii) the activated
JAK-STAT signaling pathway may further induce release
of pro-inflammatory factors and maintain the activation
of microglia.
We studied the effects of EMF exposure on cultured
N9 microglial cells and demonstrate that an initial acti-
vation of microglia is induced by EMF exposure. In
addition, many other physical factors such as infrasound
exposure, irradiation, heat shock treatment and
hyperthermia, can stimulate activation and pro-inflam-
matory reactions of microglia [96-100]. The transmem-
brane signal transduction mechanisms of microglial
activation in these physical environments remain poorly
understood. Further investigations into these transmem-
brane signal transduction mechanisms may help to pro-
tect humans against electromagnetic radiation, ionizing
radiation and other hazardous physical factors.
Conclusions
Our results strongly suggest that external electromag-
netic emission as a physical stimulation directly triggers
an initial activation of microglia and produces significant
pro-inflammatory responses. Activation of JAK2-STAT3
signaling occurs in parallel with the microglial activation
and the release of pro-inflammatory factors. Microglial
activation and pro-inflammatory responses are signifi-
cantly reduced by P6 at 12 h, but not at 3 h, after EMF
exposure. These results suggest that the JAK2-STAT3
pathway may not mediate the initial microglial activa-
tion, but does promote pro-inflammatory responses in
EMF-stimulated microglial cells. Our results provide a
basis to determine whether the pro-inflammatory
responses of EMF-stimulated microglia can be sup-
pressed by inhibition of the JAK2-STAT3 pathway in
therapeutic interventions.
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